111 Inc (YI)
0.6539
-0.03
(-3.84%)
USD |
NASDAQ |
Nov 14, 16:00
0.6539
0.00 (0.00%)
After-Hours: 18:07
111 Revenue (Quarterly): 476.09M for June 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 476.09M |
| March 31, 2024 | 493.12M |
| December 31, 2023 | 570.81M |
| September 30, 2023 | 506.50M |
| June 30, 2023 | 496.18M |
| March 31, 2023 | 540.11M |
| December 31, 2022 | 583.13M |
| September 30, 2022 | 488.85M |
| June 30, 2022 | 459.45M |
| March 31, 2022 | 469.22M |
| December 31, 2021 | 540.80M |
| September 30, 2021 | 516.70M |
| June 30, 2021 | 468.04M |
| March 31, 2021 | 399.92M |
| Date | Value |
|---|---|
| December 31, 2020 | 398.61M |
| September 30, 2020 | 341.24M |
| June 30, 2020 | 228.71M |
| March 31, 2020 | 225.69M |
| December 31, 2019 | 191.34M |
| September 30, 2019 | 158.27M |
| June 30, 2019 | 122.86M |
| March 31, 2019 | 97.11M |
| December 31, 2018 | 80.61M |
| September 30, 2018 | 73.12M |
| June 30, 2018 | 62.91M |
| March 31, 2018 | 51.90M |
| December 31, 2017 | 41.71M |
| September 30, 2017 | 37.26M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
191.34M
Minimum
Dec 2019
583.13M
Maximum
Dec 2022
441.82M
Average
476.09M
Median
Jun 2024
Revenue (Quarterly) Benchmarks
| Dr Reddy's Laboratories Ltd | 956.87M |
| Concord Medical Services Holdings Ltd | -- |
| Sinovac Biotech Ltd | -- |
| CASI Pharmaceuticals Inc | 3.979M |
| Zai Lab Ltd | 100.50M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.949M |
| Total Expenses (Quarterly) | 475.63M |
| EPS Diluted (Quarterly) | -0.0445 |
| Enterprise Value | 121.09M |
| Gross Profit Margin (Quarterly) | 6.06% |
| Profit Margin (Quarterly) | -0.41% |
| Earnings Yield | -86.16% |
| Normalized Earnings Yield | -86.38 |